309 related articles for article (PubMed ID: 20833839)
1. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.
Blumberg H; Dinh H; Dean C; Trueblood ES; Bailey K; Shows D; Bhagavathula N; Aslam MN; Varani J; Towne JE; Sims JE
J Immunol; 2010 Oct; 185(7):4354-62. PubMed ID: 20833839
[TBL] [Abstract][Full Text] [Related]
2. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
5. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.
Villadsen LS; Schuurman J; Beurskens F; Dam TN; Dagnaes-Hansen F; Skov L; Rygaard J; Voorhorst-Ogink MM; Gerritsen AF; van Dijk MA; Parren PW; Baadsgaard O; van de Winkel JG
J Clin Invest; 2003 Nov; 112(10):1571-80. PubMed ID: 14617758
[TBL] [Abstract][Full Text] [Related]
6. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice.
Nakajima A; Matsuki T; Komine M; Asahina A; Horai R; Nakae S; Ishigame H; Kakuta S; Saijo S; Iwakura Y
J Immunol; 2010 Aug; 185(3):1887-93. PubMed ID: 20610641
[TBL] [Abstract][Full Text] [Related]
7. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
Oxholm A
APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1: a key inflammatory mediator in psoriasis?
Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
[TBL] [Abstract][Full Text] [Related]
11. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
12. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
[TBL] [Abstract][Full Text] [Related]
13. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.
Rizzo HL; Kagami S; Phillips KG; Kurtz SE; Jacques SL; Blauvelt A
J Immunol; 2011 Feb; 186(3):1495-502. PubMed ID: 21172868
[TBL] [Abstract][Full Text] [Related]
14. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
[TBL] [Abstract][Full Text] [Related]
15. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
16. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
17. Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis.
Boniface K; Lecron JC; Bernard FX; Dagregorio G; Guillet G; Nau F; Morel F
Eur Cytokine Netw; 2005 Dec; 16(4):309-19. PubMed ID: 16464746
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression.
Debets R; Hegmans JP; Buurman WA; Benner R; Prens EP
Cytokine; 1996 Jan; 8(1):80-8. PubMed ID: 8742070
[TBL] [Abstract][Full Text] [Related]
19. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.
Carrier Y; Ma HL; Ramon HE; Napierata L; Small C; O'Toole M; Young DA; Fouser LA; Nickerson-Nutter C; Collins M; Dunussi-Joannopoulos K; Medley QG
J Invest Dermatol; 2011 Dec; 131(12):2428-37. PubMed ID: 21881584
[TBL] [Abstract][Full Text] [Related]
20. JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.
Chang BY; Zhao F; He X; Ren H; Braselmann S; Taylor V; Wicks J; Payan DG; Grossbard EB; Pine PR; Bullard DC
J Immunol; 2009 Aug; 183(3):2183-92. PubMed ID: 19596999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
